BeOne Medicines Schedules May 6 Release of Q1 2026 Unaudited Results and Audit Committee Review

Bulletin Express04-22

BeOne Medicines Ltd. will disclose its unaudited financial results for the quarter ended 31 March 2026 on Wednesday, 6 May 2026, after Hong Kong market close. The statements will be prepared under U.S. GAAP and the applicable U.S. SEC rules.

On the same day, the company’s audit committee will meet to review and approve the first-quarter figures.

Management will host a results conference call at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Hong Kong Time) on 6 May 2026. A live webcast and subsequently archived replay will be accessible through the investors section of the company’s website (https://ir.beonemedicines.com). Participants are advised to log in at least 15 minutes before the scheduled start.

The board of directors currently comprises Chairman and Executive Director John V. Oyler; Non-executive Director Dr. Xiaodong Wang; and Independent Non-executive Directors Dr. Olivier Brandicourt, Dr. Margaret Han Dugan, Michael Goller, Anthony C. Hooper, Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon D. Sanders, Shalini Sharp and Qingqing Yi.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1144446978?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-22 18:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144446978","market":"hk","top_or_hot":-1,"title":"BeOne Medicines Schedules May 6 Release of Q1 2026 Unaudited Results and Audit Committee Review","media":"Bulletin Express","content":"<p>BeOne Medicines Ltd. will disclose its unaudited financial results for the quarter ended 31 March 2026 on Wednesday, 6 May 2026, after Hong Kong market close. The statements will be prepared under U.S. GAAP and the applicable U.S. SEC rules.</p>\n<p>On the same day, the company’s audit committee will meet to review and approve the first-quarter figures.</p>\n<p>Management will host a results conference call at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Hong Kong Time) on 6 May 2026. A live webcast and subsequently archived replay will be accessible through the investors section of the company’s website (https://ir.beonemedicines.com). Participants are advised to log in at least 15 minutes before the scheduled start.</p>\n<p>The board of directors currently comprises Chairman and Executive Director John V. Oyler; Non-executive Director Dr. Xiaodong Wang; and Independent Non-executive Directors Dr. Olivier Brandicourt, Dr. Margaret Han Dugan, Michael Goller, Anthony C. Hooper, Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon D. Sanders, Shalini Sharp and Qingqing Yi.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BeOne Medicines Schedules May 6 Release of Q1 2026 Unaudited Results and Audit Committee Review</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeOne Medicines Schedules May 6 Release of Q1 2026 Unaudited Results and Audit Committee Review\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-22 18:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BeOne Medicines Ltd. will disclose its unaudited financial results for the quarter ended 31 March 2026 on Wednesday, 6 May 2026, after Hong Kong market close. The statements will be prepared under U.S. GAAP and the applicable U.S. SEC rules.</p>\n<p>On the same day, the company’s audit committee will meet to review and approve the first-quarter figures.</p>\n<p>Management will host a results conference call at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Hong Kong Time) on 6 May 2026. A live webcast and subsequently archived replay will be accessible through the investors section of the company’s website (https://ir.beonemedicines.com). Participants are advised to log in at least 15 minutes before the scheduled start.</p>\n<p>The board of directors currently comprises Chairman and Executive Director John V. Oyler; Non-executive Director Dr. Xiaodong Wang; and Independent Non-executive Directors Dr. Olivier Brandicourt, Dr. Margaret Han Dugan, Michael Goller, Anthony C. Hooper, Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon D. Sanders, Shalini Sharp and Qingqing Yi.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06160","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1144446978","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144446978","pubTimestamp":1776853376,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"BeOne Medicines Ltd. will disclose its unaudited financial results for the quarter ended 31 March 2026 on Wednesday, 6 May 2026, after Hong Kong market close. The statements will be prepared under...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06160":"百济神州"},"translate_title":"BeOne Medicines计划于5月6日发布2026年第一季度未经审计业绩和审计委员会审查","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06160":1},"content_text":"BeOne Medicines Ltd. will disclose its unaudited financial results for the quarter ended 31 March 2026 on Wednesday, 6 May 2026, after Hong Kong market close. The statements will be prepared under U.S. GAAP and the applicable U.S. SEC rules.\nOn the same day, the company’s audit committee will meet to review and approve the first-quarter figures.\nManagement will host a results conference call at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Hong Kong Time) on 6 May 2026. A live webcast and subsequently archived replay will be accessible through the investors section of the company’s website (https://ir.beonemedicines.com). Participants are advised to log in at least 15 minutes before the scheduled start.\nThe board of directors currently comprises Chairman and Executive Director John V. Oyler; Non-executive Director Dr. Xiaodong Wang; and Independent Non-executive Directors Dr. Olivier Brandicourt, Dr. Margaret Han Dugan, Michael Goller, Anthony C. Hooper, Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon D. Sanders, Shalini Sharp and Qingqing Yi.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1144446978","isCrawlerRequest":true}